Fig. 3From: Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysisFunnel plot. FEV1, forced expiratory volume in one secondBack to article page